Page last updated: 2024-10-28

ibuprofen and Glycogen Storage Disease Type I

ibuprofen has been researched along with Glycogen Storage Disease Type I in 1 studies

Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine

Glycogen Storage Disease Type I: An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sheth, UK1
Valame, SP1
Gupta, KC1
Baxi, AJ1
Kulkarni, VN1
Pispati, PK1

Other Studies

1 other study available for ibuprofen and Glycogen Storage Disease Type I

ArticleYear
Tolerability of ibuprofen and flurbiprofen in G-6-PD deficient subjects: in vitro study.
    British journal of clinical pharmacology, 1981, Volume: 11, Issue:3

    Topics: Erythrocytes; Female; Flurbiprofen; Glutathione; Glycogen Storage Disease Type I; Humans; Ibuprofen;

1981